![9-[(2R,3S,5S)-3-Fluoro-5-(Hydroxymethyl)Oxolan-2-Yl]-3H-Purin-6-One](https://static.cymitquimica.com/products/3D/img/FF98319.png "Cliccare per ingrandire")
9-[(2R,3S,5S)-3-Fluoro-5-(Hydroxymethyl)Oxolan-2-Yl]-3H-Purin-6-One
CAS: 117525-25-4
Rif. 3D-FF98319
| Dimensione non definita | Prezzo su richiesta |
Informazioni sul prodotto
- 2'-F-dd-Aral
- 6H-Purin-6-one, 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)-1,9-dihydro-
- 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)-3,9-dihydro-6H-purin-6-one
9-[(2R,3S,5S)-3-Fluoro-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one (FHA) is a prodrug that contains a hydroxymethyl group. FHA can be hydrolyzed by the enzyme aldehyde oxidase to form 9-[(2R,3S,5S)-3-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one (FAU). FAU is more potent than FHA and has been shown to inhibit HIV replication in cell culture. FHA was administered to humans and its pharmacokinetic properties were studied. The plasma concentration of FHA increased with time after administration and reached a maximum level at about 3 hours. The maximum concentration of FAU was found at about 1 hour. The elimination half life of both compounds was approximately 2 hours. The workstation architecture used
Proprietà chimiche
Richiesta tecnica su: 3D-FF98319 9-[(2R,3S,5S)-3-Fluoro-5-(Hydroxymethyl)Oxolan-2-Yl]-3H-Purin-6-One
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
